SLC5A2 and autosomal dominant polycystic kidney disease: However, the SGLT2 inhibitor dapagliflozin improved kidney function and reduced albuminuria but did not stop cyst growth [83] and even increased cyst size in a different rat model of autosomal dominant polycystic kidney disease (ADPKD) [84].